跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“Beprenemab”
全部
12
临床试验
2
药物
1
机构
0
资讯
9
去年
CTAD 2024: Mixed Results for Alzheimer's Therapies Highlighted
去年
Alzheimer's Clinical Trial Update: New Data on Tau-Targeting Drugs and More
去年
UCB's Bepranemab Shows Promise in Phase 2a Alzheimer's Disease Trial
去年
Roche Terminates Alzheimer's Partnership with UCB, Returns Rights to Bepranemab
去年
Bepranemab Shows Promise in Slowing Tau Accumulation in Alzheimer's Disease
去年
Bepranemab Shows Promise in Slowing Tau Accumulation and Cognitive Decline in Early Alzheimer's
去年
UCB's Bepranemab Shows Promise in Reducing Tau Tangles in Alzheimer's Subgroup
去年
Bepranemab Shows Promise in Slowing Tau Accumulation and Cognitive Decline in Early Alzheimer's
去年
UCB Evaluates Future of Bepranemab After Phase II Trial Fails to Meet Endpoints Amidst Roche Partnership Exit